Additionally, the suppression of the CCT5 gene modified the responsiveness of small-cell lung cancer to chemotherapy45, and an increase in CCT5 expression has been correlated with decreased sensitivity of breast cancer cells to doxorubicin in instances involving p53 mutations46. Here, TP53 is linked to breast carcinoma.